Advertisement

Topics

NICE recommends Xiapex for NHS in England to treat Dupuytren's contracture

10:14 EDT 3 Jul 2017 | PharmaBiz

Swedish Orphan Biovitrum AB (Sobi) announced that for the first time people in England with the disabling hand condition Dupuytren's disease will have access to Xiapex (collagenase clostridium histolyticum (CCH))

Original Article: NICE recommends Xiapex for NHS in England to treat Dupuytren's contracture

NEXT ARTICLE

More From BioPortfolio on "NICE recommends Xiapex for NHS in England to treat Dupuytren's contracture"

Advertisement
Quick Search
Advertisement
Advertisement